The product was received for evaluation.A quadrox-i oxygenator was received in the decontamination / complaints laboratory.No clots were flushed out when the oxygenator was flushed with water.The oxygenator was then cleaned with sodium hypochlorite solution.Nothing of note was found during the investigation, and for further tests, the oxygenator was sent to the qa laboratory for performance testing.The product was tested for its o2 and co2 gas exchange and pressure drop performance.All tests were passed, showing that the product is performing to specification.The patient was in a serious condition, and before this case had suffered asystole twice.The customer was sent a list of questions put together by the application therapy manager regarding the case and patient condition, but despite several attempts to obtain additional information within a good faith effort, no response was forthcoming.Consequently, without further information about the case, it is not possible to perform a clinical assessment.The available information related to anticoagulation is not clear, and the anticoagulation regime in place could have promoted clotting, but it is not possible to confirm this.No product malfunction is indicated from the investigation results.A dhr review did not identify any anomalies during production or packaging, and a search of the complaint handling database indicates that there is no systemic issue, as this was the only complaint found in the system.However, the clinical picture is not clear and there remains insufficient information to be able to accurately evaluate this case, or to establish a definitive root cause.
|